These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2025434)

  • 1. Clinical applications of contrast agents in body imaging.
    Bydder GM
    Top Magn Reson Imaging; 1991 Mar; 3(2):74-84. PubMed ID: 2025434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
    Santyr GE
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future applications of contrast agents for magnetic resonance imaging of the central nervous system.
    Bradley WG
    Invest Radiol; 1992 Aug; 27 Suppl 1():S58-60. PubMed ID: 1506155
    [No Abstract]   [Full Text] [Related]  

  • 5. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
    Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
    Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B; Laniado M; Saini S
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium-DTPA enhancement of VX-2 carcinoma of the rabbit kidney on T1 weighted magnetic resonance images.
    Yancey JM; Ackerman N; Kaude JV; Googe RE; Fitzsimmons JR; Scott KN; Mancuso AA; Hackett RL; Hager DA; Caballero S
    Acta Radiol; 1987; 28(4):479-82. PubMed ID: 2958067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concepts of myocardial perfusion imaging in magnetic resonance imaging.
    Wilke N; Jerosch-Herold M; Stillman AE; Kroll K; Tsekos N; Merkle H; Parrish T; Hu X; Wang Y; Bassingthwaighte J
    Magn Reson Q; 1994 Dec; 10(4):249-86. PubMed ID: 7873354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA].
    Pronin IN; Kornienko VN
    Zh Vopr Neirokhir Im N N Burdenko; 1995; (2):16-7. PubMed ID: 7625134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
    Mano I; Yoshida H; Kono T; Tsuchida T; Terao H; Iio M
    Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnetic resonance imaging with gadolinium-DTPA for detecting cardiac transplant rejection in rats.
    Konstam MA; Aronovitz MJ; Runge VM; Kaufman DM; Brockway BA; Isner JM; Katzen NA; Dresdale AR; Diehl JT; Kaplan E
    Circulation; 1988 Nov; 78(5 Pt 2):III87-94. PubMed ID: 3052922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media].
    Mohr U; Weissleder R
    Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value and limitation of gadolinium-DTPA contrast enhancement in the early detection of acute canine myocardial infarction.
    Nishimura T; Yamada Y; Kozuka T; Nakatani T; Noda H; Takano H
    Am J Physiol Imaging; 1987; 2(4):181-5. PubMed ID: 3451771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
    Suto Y; Shimatani Y; Kato T; Kamba M; Ohuchi Y; Kodama F; Kato T; Ohta Y
    Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of magnetic resonance contrast agents in routine cranial imaging. Case study of an evaluative method.
    Wolf GL; Walsh SJ; McNeil BJ
    Neuroimaging Clin N Am; 1994 Feb; 4(1):55-62. PubMed ID: 8130952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolated cervical intramedullary metastasis from breast cancer. Value of magnetic resonance imaging].
    Lauvin R; Cornu P; Philippon J; Gautier JC; Jacquillat C; Khayat D; Doyon D
    Rev Neurol (Paris); 1988; 144(1):40-2. PubMed ID: 3347806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of magnevist in the clinical practice (clinical trials].
    Cheremisin VM; Miakotin LL; Kovelenov AG; Trushchenko SG
    Vestn Rentgenol Radiol; 1994; (4):22-5. PubMed ID: 7785194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.